Menu Menu


GLAXF Financials       Clear


GLAXF        0001131399    
Filing Date Form Type Description Document
2020-11-25 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-11-23 6-K BLOCK LISTING INTERIM REVIEW View Document
2020-11-19 6-K HOLDING(S) IN COMPANY View Document
2020-11-17 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-11-12 6-K MEDICAGO GSK PHASE 2/3 STUDY START View Document
2020-11-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-11-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-11-09 6-K VIIV'S CABOTEGRAVIR SUPERIOR FOR HIV PREVENTION View Document
2020-11-06 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2020-11-04 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-11-04 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-11-03 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-11-03 6-K GSK SETS NEW ENVIRONMENTAL GOALS View Document
2020-11-02 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-11-02 6-K TOTAL VOTING RIGHTS View Document
2020-10-30 6-K HOLDING(S) IN COMPANY View Document
2020-10-30 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-10-28 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-10-28 6-K 3RD QUARTER RESULTS View Document
2020-10-28 6-K SANOFI AND GSK SUPPORT COVAX - 200M VACCINE DOSES View Document
2020-10-22 6-K HOLDING(S) IN COMPANY View Document
2020-10-16 6-K POSITIVE CHMP OPINION VIIV LONG-ACTING HIV REGIMEN View Document
2020-10-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-10-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-10-13 25-NSE View Document
2020-10-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-10-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-10-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-10-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-10-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-10-07 CERT NYSE CERTIFICATION View Document
2020-10-01 8-A12B 8-A12B View Document
2020-10-01 6-K 6-K View Document
2020-10-01 6-K TOTAL VOTING RIGHTS View Document
2020-10-01 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2020-09-30 424B2 424B2 View Document
2020-09-28 FWP FWP View Document
2020-09-28 FWP FWP View Document
2020-09-28 424B2 424B2 View Document
2020-09-28 6-K 6-K View Document
2020-09-22 6-K SANOFI/GSK AGREE UP TO 72M CANADA COVID DOSES View Document
2020-09-18 4 OWNERSHIP DOCUMENT View Document
2020-09-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-09-10 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-09-09 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-09-09 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-09-03 6-K SANOFI/GSK: PHASE 1/2 TRIAL OF COVID-19 VACCINE View Document
2020-09-01 6-K TOTAL VOTING RIGHTS View Document
2020-08-24 SC 13G ACQUISITION OF BENEFICIAL OWNERSHIP View Document
2020-08-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-08-06 6-K US FDA APPROVES GSKS BLENREP FOR MULTIPLE MYELOMA View Document
2020-08-03 6-K TOTAL VOTING RIGHTS View Document
2020-08-03 6-K SANOFI/GSK TO SUPPLY EU WITH 300M COVID 19 DOSES View Document
2020-08-03 SC 13D ACQUISITION OF BENEFICIAL OWNERSHIP View Document
2020-07-31 6-K SANOFI & GSK PICKED FOR OP. WARP SPEED BY US GOV. View Document
2020-07-30 4 OWNERSHIP DOCUMENT View Document
2020-07-29 6-K 2ND QUARTER RESULTS View Document
2020-07-29 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-07-29 6-K SANOFI AND GSK AGREE UK DOSES OF COVID 19 VACCINE View Document
2020-07-28 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-07-24 6-K GSK RECEIVES POSITIVE CHMP OPINION FOR BELAMAF View Document
2020-07-22 SC 13D ACQUISITION OF BENEFICIAL OWNERSHIP View Document
2020-07-22 4 OWNERSHIP DOCUMENT View Document
2020-07-20 6-K GSK AND CUREVAC ENTER COLLABORATION View Document
2020-07-16 3 OWNERSHIP DOCUMENT View Document
2020-07-16 4 OWNERSHIP DOCUMENT View Document
2020-07-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-07-15 6-K FDA PANEL VOTES IN FAVOR OF BELANTAMAB MAFODOTIN View Document
2020-07-14 3/A OWNERSHIP DOCUMENT View Document
2020-07-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-07-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-07-10 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2020-07-10 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-07-10 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-07-10 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-07-09 3 OWNERSHIP DOCUMENT View Document
2020-07-02 11-K View Document
2020-07-02 11-K View Document
2020-07-01 6-K TOTAL VOTING RIGHTS View Document
2020-06-29 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2020-06-29 6-K GSK'S DAPRODUSTAT GAINS FIRST REGULATORY APPROVAL View Document
2020-06-22 4 OWNERSHIP DOCUMENT View Document
2020-06-22 SC 13D/A AMENDED SC13D View Document
2020-06-19 6-K FDA ADVISORY COMMITTEE REVIEW BELANTAMAB MAFODOTIN View Document
2020-06-18 6-K 6-K View Document
2020-06-18 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-06-17 6-K 6-K View Document
2020-06-17 SC 13D/A SC 13D/A View Document
2020-06-16 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-06-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-06-09 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-06-04 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2020-06-01 6-K TOTAL VOTING RIGHTS View Document
2020-05-29 SD SD View Document
2020-05-26 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2020-05-26 4 View Document
2020-05-26 6-K BLOCK LISTING INTERIM REVIEW View Document
2020-05-21 4 OWNERSHIP DOCUMENT View Document
2020-05-19 6-K HOLDING(S) IN COMPANY View Document
2020-05-18 6-K VIIV PREP JAB SHOWS HIGH EFFICACY OVER DAILY PILL View Document

Find registration statements, periodic reports, and other forms by typing ticker symbol of a company.

Ticker:

Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.



We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas